Characteristics of Patients With a Survival of More Than 5 Years Without BMT
| Age . | Spleen7-150 . | PB . | Blast . | Mono . | Hb F . | BM . | Karyotype . | Length of . | Status . |
|---|---|---|---|---|---|---|---|---|---|
| (yr) . | . | WBC . | (%) . | (×109/L) . | (%) . | Blasts . | . | Survival . | . |
| . | . | (×109/L) . | . | . | . | (%) . | . | (yr) . | . |
| 1.8 | 2 | 22.2 | 0.0 | 2.4 | 11 | 5 | Normal | 5.4 | Alive |
| 1.1 | 0 | 30.0 | 0.0 | 6.0 | 2 | ND | −7 | 5.5 | Dead |
| 0.4 | 3 | 34.8 | 0.0 | 7.0 | 2 | 9 | Normal | 7.1 | Dead |
| 1.4 | 13 | 12.0 | 1.2 | 1.4 | 0 | ND | −7 | 7.3 | Dead |
| 2.2 | 4 | 29.4 | 24.0 | 1.4 | 23 | 5 | Normal | 9.4 | BMT/dead7-151 |
| 3.1 | 8 | 5.1 | 0.0 | 3.5 | 0 | 2 | −7 | 9.6 | LFU7-152 |
| 0.4 | 5 | 56.8 | 2.0 | 8.0 | 8 | 1 | Normal | 11.9 | Alive7-152 |
| Age . | Spleen7-150 . | PB . | Blast . | Mono . | Hb F . | BM . | Karyotype . | Length of . | Status . |
|---|---|---|---|---|---|---|---|---|---|
| (yr) . | . | WBC . | (%) . | (×109/L) . | (%) . | Blasts . | . | Survival . | . |
| . | . | (×109/L) . | . | . | . | (%) . | . | (yr) . | . |
| 1.8 | 2 | 22.2 | 0.0 | 2.4 | 11 | 5 | Normal | 5.4 | Alive |
| 1.1 | 0 | 30.0 | 0.0 | 6.0 | 2 | ND | −7 | 5.5 | Dead |
| 0.4 | 3 | 34.8 | 0.0 | 7.0 | 2 | 9 | Normal | 7.1 | Dead |
| 1.4 | 13 | 12.0 | 1.2 | 1.4 | 0 | ND | −7 | 7.3 | Dead |
| 2.2 | 4 | 29.4 | 24.0 | 1.4 | 23 | 5 | Normal | 9.4 | BMT/dead7-151 |
| 3.1 | 8 | 5.1 | 0.0 | 3.5 | 0 | 2 | −7 | 9.6 | LFU7-152 |
| 0.4 | 5 | 56.8 | 2.0 | 8.0 | 8 | 1 | Normal | 11.9 | Alive7-152 |